AbCellera Investor Conference Presentation Deck
JPM HEALTHCARE CONFERENCE 2024
COPYRIGHT © ABCELLERA
5
OVERVIEW
AbCellera's engine is
broadly applicable within
the $400B¹ antibody
therapeutics market.
●
●
●
11+ years of investment in technology,
teams, and infrastructure
Vertical integration from concept to clinic
Validated on 100+ therapeutic programs
Leading capabilities on difficult targets
and bispecifics
Capitalization
$1B+*
Technology & Infrastructure
$500M+
~600
in liquidity
$200M+ from non-
dilutive government
funding
$800M+ in total
cash, equivalents,
and marketable
securities
+ platform
1
investments
employees across
3 countries
engine
for end-to-end
discovery, devel ent
& clinical manufacturing
¹Market Size by 2030 Source: IQVIA
Portfolio of Partnered Programs
110*
10
12¹
Portfolio of Internal Programs
2
partner-initiated
discovery program
starts**
* As of September 30, 2023;
t As of December 31, 2022
molecules in
the clinic
internal program
starts
assets in IND-
** With downstream participationView entire presentation